Glipizide Tablet, Extended Release
Product Images NDC 50090-6765

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Glipizide (NDC 50090-6765). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by A-s Medication Solutions, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Glipizide Str)

Chemical Structure (Glipizide Str)
Chemical structure diagram of Glipizide, showing its molecular framework including rings, functional groups, and bonds consistent with the extended-release tablet form of this oral prescription drug.*
FDA Label Image

Label Image (Lbl500906765)

Label Image (Lbl500906765)
Glipizide 10 mg extended-release tablets packaging label from A-S Medication Solutions. The label includes dosage form as extended-release tablets, quantity of 30 tablets, and storage instructions to keep at 68 to 77 degrees Fahrenheit protected from moisture and humidity. NDC number 50090-6765-0 is visible on the label, along with routing information and lot number details.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.